€153.91
1.55% yesterday
L&S, Jul 05, 10:55 pm CET
ISIN
US00287Y1091
Symbol
ABBV
Sector
Industry

AbbVie Stock price

$167.25
+1.81 1.09% 1M
+5.11 3.15% 6M
+12.28 7.92% YTD
+29.63 21.53% 1Y
+52.08 45.22% 3Y
+94.26 129.14% 5Y
+109.85 191.38% 10Y
NYSE, Closing price Fri, Jul 05 2024
+3.41 2.08%
ISIN
US00287Y1091
Symbol
ABBV
Sector
Industry

Key metrics

Market capitalization $295.34b
Enterprise Value $351.31b
PER (TTM) P/E ratio 49.80
EV/FCF (TTM) EV/FCF 16.08
EV/Sales (TTM) EV/Sales 6.46
P/S ratio (TTM) P/S ratio 5.43
P/B ratio (TTM) P/B ratio 36.88
Dividend yield 3.58%
Last dividend (FY23) $5.99
Revenue growth (TTM) Revenue growth -4.12%
Revenue (TTM) Revenue $54.40b
EBIT (operating result TTM) EBIT $17.34b
Free Cash Flow (TTM) Free Cash Flow $21.85b
Cash position $18.07b
EPS (TTM) EPS $3.36
P/E forward 32.66
P/S forward 5.35
EV/Sales forward 6.36
Short interest 0.86%
Show more

Is AbbVie a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,945 stocks worldwide.

AbbVie Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a AbbVie forecast:

20x Buy
69%
9x Hold
31%

Analyst Opinions

29 Analysts have issued a AbbVie forecast:

Buy
69%
Hold
31%

Financial data from AbbVie

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '24
+/-
%
54,403 54,403
4% 4%
100%
- Direct Costs 16,870 16,870
7% 7%
31%
37,533 37,533
8% 8%
69%
- Selling and Administrative Expenses 4,244 4,244
121% 121%
8%
- Research and Development Expense 7,315 7,315
0% 0%
13%
25,974 25,974
18% 18%
48%
- Depreciation and Amortization 8,636 8,636
2% 2%
16%
EBIT (Operating Income) EBIT 17,338 17,338
26% 26%
32%
Net Profit 5,950 5,950
21% 21%
11%

In millions USD.

Don't miss a Thing! We will send you all news about AbbVie directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

AbbVie Stock News

Positive
Seeking Alpha
2 days ago
If I had to invest $100K today in Dividend Aristocrats, here's what I would do. I'd spread my investments in between my top 10 picks within the list. I show you what portfolio profile this would create, and where it falls short.
Positive
Seeking Alpha
2 days ago
AbbVie continues to navigate Humira's LOE brilliantly, with the higher rebates and lower pricing ensuring its market-leading share despite the notable impacts on the top/bottom lines. The management has also raised their FY2024 guidance despite the multiple adjustments related to the acquired IPR&D and milestones expenses. These developments underscore ABBV's robust ex-Humira portfolio growth a...
Negative
Reuters
3 days ago
AbbVie on Wednesday lowered its 2024 adjusted profit forecast as the drugmaker expects to incur $937 million in acquisition-related expenses.
More AbbVie News

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Head office United States
CEO Robert Michael
Employees 50,000
Founded 2011
Website www.abbvie.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today